The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptors (VEGFR) polymorphisms in the prediction of clinical outcome for advanced hepatocellular carcinoma receiving sorafenib.
Luca Faloppi
No relevant relationships to disclose
Mario Scartozzi
No relevant relationships to disclose
Cristian Loretelli
No relevant relationships to disclose
Maristella Bianconi
No relevant relationships to disclose
Riccardo Giampieri
No relevant relationships to disclose
Alessandro Bittoni
No relevant relationships to disclose
Michela Del Prete
No relevant relationships to disclose
Alessandra Mandolesi
No relevant relationships to disclose
Italo Bearzi
No relevant relationships to disclose
Stefano Cascinu
No relevant relationships to disclose